FR16C0031I1 - - Google Patents

Info

Publication number
FR16C0031I1
FR16C0031I1 FR16C0031C FR16C0031I1 FR 16C0031 I1 FR16C0031 I1 FR 16C0031I1 FR 16C0031 C FR16C0031 C FR 16C0031C FR 16C0031 I1 FR16C0031 I1 FR 16C0031I1
Authority
FR
France
Prior art keywords
hiv
mercaptoacetanilides
conr
triazolyl
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR16C0031I1 publication Critical patent/FR16C0031I1/fr
Application granted granted Critical
Publication of FR16C0031I2 publication Critical patent/FR16C0031I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Pens And Brushes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR16C0031C 2004-08-25 2016-07-29 S-triazolyl alpha -mercaptoacetanilides en tant qu'inhibiteurs de la transcriptase inverse du vih Active FR16C0031I2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60422004P 2004-08-25 2004-08-25
US60421904P 2004-08-25 2004-08-25
US68635105P 2005-05-31 2005-05-31
EP05790722A EP1789039B1 (fr) 2004-08-25 2005-08-25 S-triazolyl alpha-mercaptoacetanildes tenant lieu d'inhibiteurs de la transcriptase inverse vih

Publications (2)

Publication Number Publication Date
FR16C0031I1 true FR16C0031I1 (fr) 2016-09-23
FR16C0031I2 FR16C0031I2 (fr) 2017-03-31

Family

ID=36000576

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0031C Active FR16C0031I2 (fr) 2004-08-25 2016-07-29 S-triazolyl alpha -mercaptoacetanilides en tant qu'inhibiteurs de la transcriptase inverse du vih

Country Status (32)

Country Link
US (8) US7947721B2 (fr)
EP (5) EP1789039B1 (fr)
JP (2) JP4952943B2 (fr)
KR (1) KR101241716B1 (fr)
CN (2) CN101817793B (fr)
AT (2) ATE540677T1 (fr)
AU (2) AU2005280130C9 (fr)
BR (2) BRPI0514630B8 (fr)
CA (1) CA2578068C (fr)
CY (2) CY1112221T1 (fr)
DK (1) DK2135608T3 (fr)
EA (2) EA015846B1 (fr)
EC (1) ECSP077322A (fr)
ES (2) ES2380604T3 (fr)
FR (1) FR16C0031I2 (fr)
HK (1) HK1133582A1 (fr)
HR (1) HRP20130075T1 (fr)
HU (1) HUS1600034I1 (fr)
IL (3) IL181523A (fr)
IN (1) IN2014CN03762A (fr)
LT (1) LTC2135608I2 (fr)
LU (1) LU93169I2 (fr)
ME (1) ME01512B (fr)
MX (1) MX2007002236A (fr)
NL (1) NL300825I2 (fr)
NZ (2) NZ581376A (fr)
PL (1) PL2135608T3 (fr)
PT (1) PT2135608E (fr)
RS (1) RS52632B (fr)
SG (2) SG155246A1 (fr)
SI (1) SI2135608T1 (fr)
WO (1) WO2006026356A2 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0514630B8 (pt) * 2004-08-25 2021-05-25 Ardea Biosciences Inc compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticas
WO2007050087A1 (fr) 2004-08-25 2007-05-03 Ardea Biosciences, Inc. Acides N[S(4-aryltriazol-3-yl)α-mercaptoacétyl]-p-aminobenzoïques EN TANT QU'INHIBITEURS DE TRANSCRIPTASE INVERSE DE VIH
EA016386B1 (ru) 2007-05-30 2012-04-30 Ф. Хоффманн-Ля Рош Аг Ненуклеозидные ингибиторы обратной транскриптазы
WO2009030996A1 (fr) * 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Composés triazole utilisés comme agonistes du récepteur de type toll (tlr)
BRPI0819847B1 (pt) 2007-11-27 2022-01-11 Ardea Biosciences, Inc Compostos e composições
US8193234B2 (en) * 2008-09-04 2012-06-05 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
US8242154B2 (en) 2008-09-04 2012-08-14 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
US8173690B2 (en) * 2008-09-04 2012-05-08 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
US20110244049A1 (en) * 2008-10-24 2011-10-06 Ardea Biosciences Inc. Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using same
WO2010048592A1 (fr) * 2008-10-24 2010-04-29 Ardea Biosciences, Inc. Compositions comprenant l'acide 4-(2-(5-bromo-4-(1- cyclopropylnaphtalén-4-yl)-4h-1,2,4-triazol-3-ylthio)acétamido-3- chlorobenzoïque et ses sels de qualité pharmaceutique
EP2432468A2 (fr) 2009-05-20 2012-03-28 Ardea Biosciences, Inc. Procédés pour moduler des taux d'acide urique
CN102040546B (zh) * 2009-10-10 2014-10-15 台州市华南医化有限公司 一种4-环丙基-1-异硫氰基萘的制备方法及中间体4-环丙基-1-萘甲醛肟/卤化物
ES2563207T3 (es) * 2010-01-08 2016-03-11 Ardea Biosciences, Inc. Formas polimorfas, cristalinas y en mesofases de 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4H-1,2,4-triazol-3-iltio)acetato de sodio y sus usos
EP3659601A1 (fr) 2010-03-30 2020-06-03 Ardea Biosciences, Inc. Traitement de la goutte
JP5964821B2 (ja) 2010-06-15 2016-08-03 アルデア バイオサイエンシーズ インク． 痛風と高尿酸血症の処置
AR081930A1 (es) 2010-06-16 2012-10-31 Ardea Biosciences Inc Compuestos de tioacetato
JP5709146B2 (ja) 2010-06-16 2015-04-30 アルデア バイオサイエンシーズ インク． フェニルチオ酢酸化合物、組成物、および、その使用方法
CN101899013B (zh) * 2010-07-12 2012-07-25 山东大学 2-(2-取代芳基-2h-1,2,4-三唑-3-巯基)乙酰胺衍生物及其制备方法与应用
WO2012050589A1 (fr) * 2010-10-15 2012-04-19 Ardea Biosciences, Inc. Méthodes de traitement de l'hyperuricemie et de maladies liées
PL2658846T3 (pl) 2010-12-30 2017-05-31 Ardea Biosciences, Inc. Polimorficzne postaci kwasu 2-(5-bromo-4-(4-cyklopropylo-naftalen-1-ylo)-4h-1,2,4-triazol-3-ilotio)octowego i jego zastosowania
HUE040625T2 (hu) 2011-11-03 2019-03-28 Ardea Biosciences Inc 3,4-Diszubsztituált piridinvegyület, alkalmazási eljárása és ezt tartalmazó készítmények
AR091651A1 (es) 2012-07-03 2015-02-18 Ardea Biosciences Inc Elaboracion de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico
WO2014198241A1 (fr) * 2013-06-14 2014-12-18 Sunshine Lake Pharma Co., Ltd. Dérivés de thio-1,2,4-triazole et leur procédé de préparation
CN103524440B (zh) * 2013-10-15 2015-09-09 苏州鹏旭医药科技有限公司 痛风治疗药Lesinurad的制备方法及Lesinurad中间体
AU2014351486C1 (en) * 2013-11-22 2019-06-06 Crystal Pharmatech Co., Ltd. Crystalline forms of lesinurad and its sodium salt
CN104557748A (zh) * 2014-01-25 2015-04-29 广东东阳光药业有限公司 硫代-1,2,4-三唑衍生物的新的固体形态
CN105315218A (zh) * 2014-07-17 2016-02-10 天津药物研究院 一种制备lesinurad中间体1-萘基三唑硫酮的方法
CN104326993B (zh) * 2014-10-27 2016-08-17 张远强 一种硝基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104327000B (zh) * 2014-10-27 2016-08-17 张远强 苯基取代的三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104326998B (zh) * 2014-10-27 2016-08-17 张远强 苯基取代的三氮唑丙二酸类化合物、其制备方法及用途
CN104341363B (zh) * 2014-10-27 2016-08-17 张远强 一种硝基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104341362B (zh) * 2014-10-27 2016-07-13 张远强 三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104341361B (zh) * 2014-10-27 2017-01-11 张远强 一种腈基取代三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104370841B (zh) * 2014-10-27 2016-07-13 张远强 三氮唑亚磺酰丙二酸类化合物、其制备方法及用途
CN104370842B (zh) * 2014-10-27 2016-07-13 张远强 苯基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
CN104311498B (zh) * 2014-10-27 2016-04-06 张远强 烷氧基取代的三氮唑磺酰丙二酸类化合物、其制备方法及用途
EP3112334A1 (fr) 2015-06-29 2017-01-04 DPx Fine Chemicals Austria GmbH & CoKG Procédé de fabrication de 1-cyclopropyl-naphthalènes
CN104987311A (zh) * 2015-06-30 2015-10-21 安徽万邦医药科技有限公司 一种[4-(4-环丙基萘-1-基)-5-硝基- 4h-[1,2,4]三唑-3-基硫烷基]-乙酸乙酯的制备方法及其中间体(5-硝基-4h-[1,2,4]三唑-3-基硫基)-乙酸乙酯
CN105153056A (zh) * 2015-07-01 2015-12-16 安徽万邦医药科技有限公司 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法
CN105017168A (zh) * 2015-07-01 2015-11-04 安徽万邦医药科技有限公司 一种[5-溴-4-(4-环丙基萘-1-基)-4h-[1,2,4]三唑-3-基硫烷基]-乙酸甲酯的新制备方法
WO2017036884A1 (fr) 2015-08-28 2017-03-09 Sandoz Ag Co-cristal de lésinurad, forme libre/ester éthylique de lésinurad
CN105566237B (zh) * 2016-03-01 2018-05-18 山东大学 一种治疗痛风的三唑巯乙酸类化合物的制备方法
CN109476611B (zh) 2016-06-17 2022-08-23 南京明德新药研发有限公司 一种卤代化合物及其轴手性异构体
EP3281941B1 (fr) 2016-08-11 2019-07-24 Zentiva K.S. Procédé de préparation d'acide 2-(5-bromo-4-(1-cyclopropylnaphtalén-4-yl)-4h-1,2,4-triazol-3-ythio) acétique
EP3372592A1 (fr) 2017-03-07 2018-09-12 Zentiva, k.s. Formes solides de sels d'amines de lesinurad
US10351537B2 (en) * 2017-03-10 2019-07-16 Apotex Inc. Processes for the preparation of lesinurad and intermediates thereof
EP3315494A1 (fr) 2017-04-19 2018-05-02 Química Sintética, S.A. Forme amorphe de lésinurad et ses procédés de préparation
CN108947919B (zh) 2017-05-17 2023-05-02 上海奥博生物医药股份有限公司 一种抗痛风药Lesinurad的新型制备方法及其关键中间体
WO2019001325A1 (fr) * 2017-06-28 2019-01-03 苏州科睿思制药有限公司 Forme cristalline xv de lésinurad et son procédé de préparation
EP3498697A1 (fr) 2017-12-12 2019-06-19 Química Sintética, S.A. Nouveaux sels et polymorphes de lesinurad
CN117279880A (zh) 2021-05-28 2023-12-22 住友化学株式会社 环烷基溴的制造方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2006A (en) * 1841-03-16 Clamp for crimping leather
US2009A (en) * 1841-03-18 Improvement in machines for boring war-rockets
US226186A (en) 1880-04-06 Car-coupling
US2008A (en) * 1841-03-18 Gas-lamp eok conducting gas pkom ah elevated buhner to one below it
JPS5641637B2 (fr) 1973-11-26 1981-09-29
US6832996B2 (en) 1995-06-07 2004-12-21 Arthrocare Corporation Electrosurgical systems and methods for treating tissue
JPH07215940A (ja) 1994-01-27 1995-08-15 Torii Yakuhin Kk 抗ウイルス活性を有する化合物
AU6144098A (en) 1997-02-14 1998-09-08 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
US6245817B1 (en) 1997-02-14 2001-06-12 Bayer Corporation NPY5 receptor antagonists and methods for using same
JPH10243033A (ja) * 1997-02-28 1998-09-11 Oki Electric Ind Co Ltd 復調装置
BRPI9909191B8 (pt) 1998-03-27 2021-07-06 Janssen Pharmaceutica Nv derivados de pirimidina inibidores do hiv, seu uso e composição farmacêutica que os compreende
CA2349904A1 (fr) 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Antagonistes de recepteurs du crf et methodes associees
AU2217200A (en) 1998-12-23 2000-07-12 Neurogen Corporation 2-amino-9-alkylpurines: gaba brain receptor ligands
KR20010089708A (ko) * 1998-12-25 2001-10-08 시오노 요시히코 Ｈｉｖ 인테그라제 저해 활성을 갖는 방향족 복소환 유도체
US6593077B2 (en) 1999-03-22 2003-07-15 Special Materials Research And Technology, Inc. Method of making thin films dielectrics using a process for room temperature wet chemical growth of SiO based oxides on a substrate
EP1363877A2 (fr) 2001-03-02 2003-11-26 SmithKline Beecham Corporation Benzophenones en tant qu'inhibiteurs de la transcriptase inverse
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
AU2003222648A1 (en) 2002-05-13 2003-12-02 Eli Lilly And Company Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
AU2003295324B2 (en) 2002-08-23 2008-08-28 Ardea Biosciences,Inc. Non-nucleoside reverse transcriptase inhibitors
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
BRPI0407329A (pt) 2003-02-07 2006-01-10 Janssen Pharmaceutica Nv Derivados de pirimidina para a prevenção de infecção de hiv
ES2361835T3 (es) 2003-09-25 2011-06-22 Janssen Pharmaceutica Nv Derivados de purina inhibidores de la replicación del hiv.
US20080031901A1 (en) * 2004-09-24 2008-02-07 Abbott Laboratories Sustained release monoeximic formulations of opioid and nonopioid analgesics
US7517998B2 (en) 2004-06-01 2009-04-14 Boehringer Ingelheim International Gmbh Non nucleoside reverse transcriptase inhibitors
WO2007050087A1 (fr) * 2004-08-25 2007-05-03 Ardea Biosciences, Inc. Acides N[S(4-aryltriazol-3-yl)α-mercaptoacétyl]-p-aminobenzoïques EN TANT QU'INHIBITEURS DE TRANSCRIPTASE INVERSE DE VIH
BRPI0514630B8 (pt) 2004-08-25 2021-05-25 Ardea Biosciences Inc compostos de alfa-mercaptoacetanilidas de s-triazolila e composições farmacêuticas
BRPI0819847B1 (pt) 2007-11-27 2022-01-11 Ardea Biosciences, Inc Compostos e composições
US20110244049A1 (en) 2008-10-24 2011-10-06 Ardea Biosciences Inc. Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof, and methods for preparing and using same
WO2010048592A1 (fr) 2008-10-24 2010-04-29 Ardea Biosciences, Inc. Compositions comprenant l'acide 4-(2-(5-bromo-4-(1- cyclopropylnaphtalén-4-yl)-4h-1,2,4-triazol-3-ylthio)acétamido-3- chlorobenzoïque et ses sels de qualité pharmaceutique
TWM377707U (en) * 2009-09-16 2010-04-01 Nat Energy Technology Co Ltd Assembly of power supply

Also Published As

Publication number Publication date
RS52632B (en) 2013-06-28
EA014737B1 (ru) 2011-02-28
IL181523A (en) 2013-12-31
MX2007002236A (es) 2007-07-09
ATE528001T1 (de) 2011-10-15
AU2005280130C1 (en) 2010-02-18
US7947721B2 (en) 2011-05-24
EA015846B1 (ru) 2011-12-30
JP4952943B2 (ja) 2012-06-13
LTPA2016024I1 (lt) 2016-09-12
CN101817793B (zh) 2014-01-08
US20110313157A1 (en) 2011-12-22
ECSP077322A (es) 2007-04-26
PT2135608E (pt) 2012-01-13
US20100267724A2 (en) 2010-10-21
BRPI0514630B8 (pt) 2021-05-25
US8003681B2 (en) 2011-08-23
AU2005280130A1 (en) 2006-03-09
AU2009217458B2 (en) 2009-11-19
US8252828B2 (en) 2012-08-28
CY2016028I1 (el) 2016-12-14
LU93169I2 (fr) 2016-10-10
AU2005280130C9 (en) 2010-03-04
CN101083987B (zh) 2011-01-26
SG155246A1 (en) 2009-09-30
ES2374773T3 (es) 2012-02-21
EP1789039B1 (fr) 2012-01-11
HUS1600034I1 (hu) 2016-09-28
AU2005280130B2 (en) 2009-09-10
EP2609917A1 (fr) 2013-07-03
EP2402011A1 (fr) 2012-01-04
ATE540677T1 (de) 2012-01-15
EP1789039A2 (fr) 2007-05-30
AU2009217458A1 (en) 2009-10-15
WO2006026356A3 (fr) 2006-08-10
CA2578068A1 (fr) 2006-03-09
ES2380604T3 (es) 2012-05-16
IL219131A0 (en) 2012-06-28
JP2008510828A (ja) 2008-04-10
WO2006026356A2 (fr) 2006-03-09
CY2016028I2 (el) 2016-12-14
NL300825I2 (fr) 2017-01-24
JP5457472B2 (ja) 2014-04-02
CY1112221T1 (el) 2015-12-09
US20080176850A1 (en) 2008-07-24
US20100081827A1 (en) 2010-04-01
SI2135608T1 (sl) 2012-03-30
JP2012077088A (ja) 2012-04-19
ME01512B (me) 2014-04-20
CN101817793A (zh) 2010-09-01
AU2009217458A8 (en) 2009-10-29
US20110190491A1 (en) 2011-08-04
US8946273B2 (en) 2015-02-03
EP1789039A4 (fr) 2009-08-05
FR16C0031I2 (fr) 2017-03-31
NZ553534A (en) 2010-10-29
LTC2135608I2 (lt) 2017-07-25
CA2578068C (fr) 2011-08-09
HK1133582A1 (en) 2010-04-01
BRPI0514630B1 (pt) 2020-09-15
EA200901186A1 (ru) 2010-04-30
SG185992A1 (en) 2012-12-28
DK2135608T3 (da) 2012-01-23
EA200700488A1 (ru) 2007-08-31
CN101083987A (zh) 2007-12-05
BRPI0520870B8 (pt) 2021-05-25
US20100069645A1 (en) 2010-03-18
US20180002296A1 (en) 2018-01-04
IL201546A (en) 2013-10-31
BRPI0520870B1 (pt) 2020-11-10
US20150094284A1 (en) 2015-04-02
EP2433633A1 (fr) 2012-03-28
PL2135608T3 (pl) 2012-07-31
KR20070054694A (ko) 2007-05-29
KR101241716B1 (ko) 2013-03-08
NZ581376A (en) 2011-05-27
HRP20130075T1 (hr) 2013-02-28
EP2135608B1 (fr) 2011-10-12
EP2135608B8 (fr) 2012-03-21
US20120283301A1 (en) 2012-11-08
BRPI0514630A (pt) 2008-06-17
EP2135608A1 (fr) 2009-12-23
IN2014CN03762A (fr) 2015-09-25
EP2402011B1 (fr) 2012-11-14
IL181523A0 (en) 2007-07-04
US8481581B2 (en) 2013-07-09

Similar Documents

Publication Publication Date Title
FR16C0031I1 (fr)
GB2371066B8 (en) Tubulars with expandable cells and locking mechanisms
WO2005032488A3 (fr) Sulfonylurees 2,4-dioxo-3-quinazolinylaryl
USD488195S1 (en) Craft kit construction component-leaf form with through-hole
DE602005011031D1 (en) Phosphoindole als hiv-inhibitoren
USD527056S1 (en) Craft kit construction component—tear-drop form with through-hole
AU2003243765A8 (en) 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
UA89200C2 (ru) S-ТРИАЗОЛИЛ-б-МЕРКАПТОАЦЕТАНИЛИДЫ КАК ИНГИБИТОРЫ ОБРАТНОЙ ТРАНСКРИПТАЗЫ ВИЧ
AP2005003248A0 (en) 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as reverse transcriptase modulators in the treatment of I. A. HIV.
USD475098S1 (en) Craft kit construction component—leg form
WO2004096147A3 (fr) Composes d'oxo-pyrimidine
USD472406S1 (en) Table
AR028458A1 (es) Un estuche de combinacion usado en el tratamiento del paludismo
RU2002135779A (ru) Лекарственное средство
RU2006146820A (ru) Средство связи
TH54449EX (th) อุปกรณ์ควบคุมไร้สาย
JP2003334596A5 (fr)
AP2005003429A0 (en) 5,7-Diaminopyrazolo Ä4,3-DÜ pyrimidines useful in the treatment of hypertension.